[1] Lin S, Gao K, Gu S, et al.Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years[J]. Cancer, 2021, 127(21): 4030-4039. [2] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 ountries[J]. CA Cancer J Clin, 2021, 71(3) : 209-249. [3] 陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13. [4] 孟令昊, 胥秋艳, 李科, 等. 1990—2019 年中国女性宫颈癌疾病负担变化的分析[J]. 中国循证医学杂志, 2021, 21(6): 648-653. [5] Lefevere E, Theeten H, Hens N, et al.From non school-based, co-payment to school-based, free human papillomavirus vaccination in Flanders(Belgium): A retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities[J]. Vaccine, 2015, 33(39): 5188-5195. [6] 李想, 刘灿, 周维, 等. 2005—2015年中国宫颈癌发病与死亡趋势分析[J]. 华中科技大学学报(医学版), 2021, 5(3) :325-330. [7] Utami TW, Andrijono A, Putra A, et al.Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030:A cross-sectional study[J]. Clin Exp Vaccine Res, 2022, 11(2): 141. [8] 中国优生科学协会阴道镜和子宫颈病理学分会, 中华医学会妇科肿瘤学分会, 中国抗癌协会妇科肿瘤专业委员会,等. 中国子宫颈癌筛查指南(一)[J]. 现代妇产科进展, 2023, 32(7): 481-487. [9] 何文凤, 王莉辉, 曾红燕, 等. 深圳市罗湖区女性HPV感染分布特点及类型特征分析[J]. 中国实验诊断学, 2021, 25(8): 1172-1176. [10] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens[J]. IARC Monogr Eval Carcinog Risks Hum, 2012, 100B(1): 1-441. [11] Massad LS,Einstein MH,Huh WK,et al.2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J]. J Low Genit Tract Dis, 2013, 17: S1. [12] 张仲华,刘晨瑛,任会叶,等. 2003—2018 年间中国女性宫颈癌发病与死亡趋势研究[J]. 中华疾病控制杂志, 2022, 26(1): 14-20. [13] Dickson EL, Vogel RI, Bliss RL, et al.Multiple-type human papillomavirus (HPV) infections: A cross-sectional analysis of the prevalence of specific types in 309 000 women referred for HPV testing at the time of cervical cytology[J]. Int J Gynecol Cancer, 2013, 23(7): 1295-1302. [14] Sasagawa T, Maehama T, IDETA K, et al.Population-based study for human papillomavirus (HPV) infection in young women in Japan: A multicenter study by the Japanese human papillomavirus disease education research survey group (J- HERS)[J]. J Med Virol, 2016, 88(2): 324-335. [15] Gallegos-bolanos J, Rivera-Dominnguezj A, Presno-Bernal JM, et al. High prevalence of co- infection between human papillomavirus (HPV) 51 and 52 in Mexican population[J]. BMC Cancer, 2017, 1(1): 531. [16] 靳大川, 郭宇辉. 郑州市女性人乳头状瘤病毒感染的流行病学特征及分析[J]. 医学研究杂志, 2017, 46(11): 88-92. [17] 张爱凤, 贾丽华, 裴俊丽, 等. 北京通州地区女性生殖道高危型HPV感染现状与宫颈疾病关系的研究[J]. 中国妇产科临床杂志, 2020, 21(01): 58-59. [18] 罗秋兰, 李菲, 陈春元, 等. 深圳市光明区10 717例女性人乳头状瘤病毒感染亚型分型[J].汕头大学医学院学报, 2019, 32(2): 115-117. [19] 何成山, 马晨芸, 陆志成. 上海部分区域人乳头瘤状病毒基因分型及感染状况[J]. 职业与健康, 2018, 34(16): 2226-2229. [20] 杜宏, 索兰草, 刘红贤, 等.甘肃地区女性宫颈HPV感染现状[J]. 实用预防医学杂志, 2015, 22(1): 17-20. [21] 索南草, 严彬, 陈剑虹, 等. 兰州市城区育龄妇女人乳头瘤病毒感染状况调查[J].中国妇幼保健杂志, 2015, 30(10): 1579-1580. [22] 刘文姬, 刘志强, 郭庆枝, 等. HPV疫苗接种及其对宫颈癌筛查方案影响研究进展[J]. 现代妇产科进展, 2018, 27(3): 228-231. [23] De Sanjose S, Wim GVQ, Laia A, et al.Human papilloma virus genotype attribution in invasive cervical cancer:A retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010, 11(11): 1048-1056. [24] Bao YP, Li N, Smith JS, et al.Human papillomavirus type distribution in women from Asia: A meta-analysis[J]. Int JGynecol Cancer, 2008, 18(1): 71-79. [25] 孙梦, 沈杨. 南京地区年轻女性HPV感染及宫颈疾病情况分析[J]. 东南大学学报(医学版), 2017, 36(5): 781-784. [26] 孟凡萍, 郝坡. 渝东北地区7 401例女性HPV感染基因分型分析[J]. 国际检验医学杂志,2018, 39(8): 986-988. |